Observe Medical ASA Income Statement

Financials in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	18.81	17.23	27.94	19.52	24.04
Other Revenue	-	1.26	-	-	-
Revenue	18.81	18.48	27.94	19.52	24.04
Revenue Growth (YoY)	1.77%	-33.85%	43.14%	-18.80%	711.96%
Cost of Revenue	14.11	15.41	18.66	14.34	14.52
Gross Profit	4.7	3.07	9.29	5.18	9.52
Selling, General & Admin	15.89	15.29	24.22	27.31	17.26
Other Operating Expenses	12.83	17.81	28.02	26.08	20.72
Operating Expenses	42.04	47.47	66.39	64.32	41.44
Operating Income	-37.34	-44.4	-57.1	-59.14	-31.93
Interest Expense	-5.17	-9.55	-6.65	-3.82	-3.33
Interest & Investment Income	0	1.78	0.06	0.28	-
Currency Exchange Gain (Loss)	3.46	-5.42	-4.28	1.64	4.64
Other Non Operating Income (Expenses)	39.04	-0.02	-1.82	0.65	-0.43
EBT Excluding Unusual Items	-0.02	-57.61	-69.78	-60.39	-31.04
Merger & Restructuring Charges	-	-	-	-	-4.62
Impairment of Goodwill	-	-2.68	-67.11	-	-
Asset Writedown	-41.73	-	-	-	-
Other Unusual Items	-6.9	1.56	1.81	9.67	9.34
Pretax Income	-48.64	-58.73	-135.08	-50.73	-26.32
Income Tax Expense	-	-	0.02	0.08	-
Net Income	-48.64	-58.73	-135.1	-50.8	-26.32
Net Income to Common	-48.64	-58.73	-135.1	-50.8	-26.32
Shares Outstanding (Basic)	67	15	4	3	1
Shares Outstanding (Diluted)	67	15	4	3	1
Shares Change (YoY)	336.95%	297.36%	22.13%	140.67%	18.29%
EPS (Basic)	-0.73	-3.85	-35.17	-16.15	-20.14
EPS (Diluted)	-0.73	-3.90	-35.17	-16.20	-20.14
Free Cash Flow	-25.97	-29.27	-32.47	-52.74	-22.34
Free Cash Flow Per Share	-0.39	-1.92	-8.45	-16.77	-17.09
Gross Margin	24.98%	16.63%	33.24%	26.52%	39.59%
Operating Margin	-198.51%	-240.21%	-204.36%	-302.97%	-132.79%
Profit Margin	-258.57%	-317.74%	-483.50%	-260.24%	-109.48%
Free Cash Flow Margin	-138.07%	-158.38%	-116.21%	-270.16%	-92.94%
EBITDA	-26.37	-32.56	-46.82	-51.61	-31.11
EBITDA Margin	-140.19%	-176.18%	-167.56%	-264.36%	-129.38%
D&A For EBITDA	10.97	11.84	10.28	7.54	0.82
EBIT	-37.34	-44.4	-57.1	-59.14	-31.93
EBIT Margin	-198.51%	-240.21%	-204.36%	-	-132.79%
Advertising Expenses	0.02	0.14	0.11	0.3	0.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.